Recombinant CEACAM 1 peptide is 35-143 aa residues of human Carcinoembryonic antigen-related cell adhesion molecule 1
(CEACAM1) N-terminal domain produced in E.coli.
Recombinant CEACAM 1 Peptide
Description
The carcinoembryonic antigen (CEA) family is composed of 29 genes tandemly arranged on chromosome 19q13.2. Based on nucleotide homologies, these genes are classified into 2 major subfamilies, the CEACAM and the pregnancy-specific glycoprotein (PSG) subgroups. The CEACAM-encoded proteins include CEA, CEACAM1, and other CEA gene members . CEACAM1 (Carcinoembryonic antigen related cell adhesion molecule 1; also BGP1, CD66a), is involved in the regulation of important biological processes, such asinsulin homeostasis , angiogenesis, and modulation of the immune response.
Additional information
Size | 300 µg |
---|---|
Application | Clinical diagnostics| Life Sciences |
Product type | Reagents for research |
Reagent type | Recombinant protein |
Category | Tumor markers |
Subcategory | CEACAM 1 peptide. Carcinoembryonic antigen-related cell adhesion molecule 1. |
Technical information
Accession number | UniProtKB/Swiss-Prot: P13688.2 |
---|---|
Organism | Human |
Size | 300 µg |
Expression system | E.coli |
Tag | no tagged |
Purity | >90% |
Form | Liquid, 20mM phosphate buffer pH7.5, 0.5M NaCl, 2mM EDTA, 2mM DTT, 1% sucrose, 10% glycerol. |
Tested application | SDS-PAGE, WB |
Shipping/storage conditions | Shipped at -20°C. The protein is stable for 12 months if stored at -80°C. Avoid freeze-thaw cycles. |
Usage | For Laboratory Research Use Only |